Recent Updates
Recently added Catalysts
BHC Positive Sentiment Score: 70/100

Investor Contact: Media Contact: Mark Maico Kevin Wiggins ir@bauschhealth.com corporate.communications@bauschhealth.com (877) 281-6642 (toll free) (908) 541-3785 Julia Kosygina media@kkr.com (212) 750-8300 Bausch Health

Key Takeaway: Bausch Health Companies Inc. has announced a $600 million non-recourse financing facility with KKR, providing additional liquidity for its operations. The facility will be secured by certain accounts receivables and is expected to support general corporate purposes over a term of approximately five years. This move reflects Bausch Health's ongoing strategy to strengthen its financial position and ensure operational efficiency.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bausch Health secures a substantial $600 million financing facility.
  • The financing improves liquidity for Bausch Health, supporting corporate purposes.
  • The collaboration with KKR enhances Bausch Health's financial stability.

Full Press Release Details

Investor Contact: Media Contact:
Mark Maico Kevin Wiggins
ir@bauschhealth.com corporate.communications@bauschhealth.com
(877) 281-6642 (toll free) (908) 541-3785
Julia Kosygina
media@kkr.com
(212) 750-8300
Bausch Health Enters Into $600 Million Financing Facility With KKR
LAVAL, Quebec, July 7, 2023 Bausch Health Companies Inc. (NYSE/TSX: BHC) and KKR today announced that Bausch Receivables Funding LP, an Ontario
limited partnership and wholly-owned subsidiary of Bausch Health, has entered into a $600 million non-recourse financing facility with KKR and its credit funds and accounts. The facility will be
collateralized by certain accounts receivables originated by a wholly-owned subsidiary of Bausch Health.
Bausch Health expects to utilize the proceeds
from the facility for general corporate purposes. The facility provides access to additional liquidity for a term of approximately five years.
Lokey, Inc. acted as the Company s financial advisor. Finacity Corporation acted as the administrator for the program, providing analytic and execution support, and is responsible for ongoing program administration and reporting.
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people s lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology,
neurology, dermatology, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing
global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Forward-Looking Statements About Bausch Health
This news release may contain forward-looking statements about the future performance of Bausch Health, which may generally be identified by the use of the
words anticipates, hopes, expects, intends, plans, should, could, would, may, believes, subject to and variations or
similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the
forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health s overall business, including those more fully described in Bausch Health s most recent annual report on Form
10-K and detailed from time to time in Bausch Health s other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by
KKR is a leading global
investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people
and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR s insurance subsidiaries offer
retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about
KKR & Co. Inc. (NYSE: KKR), please visit KKR s website at www.kkr.com and on Twitter @KKR_Co.
Finacity, a White Oak Global Advisors Company, specializes in the structuring and provision of efficient capital markets receivables funding programs, supplier
and payables finance, back-up servicing, and program administration. Finacity currently facilitates the financing and administration of an annual receivables volume of approximately US $150 billion. With
resources in the USA, Europe, Latin America, and Asia, Finacity conducts business throughout the world with obligors in 175 countries. Finacity is affiliated with White Oak Global Advisors, LLC, a leading alternative debt manager specializing in
originating and providing financing solutions to facilitate the growth, refinancing, and recapitalization of small and medium enterprises. For further information, please visit www.finacity.com.

Frequently Asked Questions

What is the amount of the financing facility Bausch Health secured?

Bausch Health has secured a $600 million financing facility.

Who acted as the financial advisor for Bausch Health's financing?

Lokey, Inc. served as the financial advisor for Bausch Health.

What will Bausch Health use the financing proceeds for?

Bausch Health plans to use the proceeds for general corporate purposes.

How long is the term of Bausch Health's financing facility?

The financing facility has a term of approximately five years.

Which firm provides ongoing administration for the financing program?

Finacity Corporation is responsible for the ongoing program administration.

Last updated: Jul 7, 2023